Additionally, radiation therapy can induce systemic antitumor immune reaction via the induction of immunogenic cell death, facilitation of antigen presentation or epitope, upregulation of surface receptors, and activation of T cells.[24, 28] In MM, treatment efficacy of bortezomib and another anti‐CD38 murine mAb has been reported to be improved after radiolabeled with 153Sm or 90Y.[4, 29] The addition of radiotherapy was hypothesized to increase therapeutic efficacy without introducing new chemotherapy drugs. The gene discussed is CD38; the disease is Miyoshi myopathy.